n-acetylneuraminoyllactose has been researched along with Distal Myopathies in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Malicdan, MC; Nishino, I; Noguchi, S | 1 |
Choi, J; Go, H; Kim, L; Kim, MY; Park, DB; Park, E; Park, YE; Shin, JH; Sung, NJ | 1 |
Cho, A; Hayashi, YK; Malicdan, MC; Mine, T; Nishino, I; Noguchi, S; Nonaka, I; Yamamoto, T; Yonekawa, T | 1 |
1 review(s) available for n-acetylneuraminoyllactose and Distal Myopathies
Article | Year |
---|---|
[Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
Topics: Administration, Oral; Animals; Disease Models, Animal; Distal Myopathies; Drug Evaluation, Preclinical; Hexosamines; Humans; Inclusion Bodies; Lactose; Mice; Mice, Transgenic; N-Acetylneuraminic Acid; Sialic Acids; Vacuoles | 2010 |
1 trial(s) available for n-acetylneuraminoyllactose and Distal Myopathies
Article | Year |
---|---|
Pharmacokinetics and clinical efficacy of 6'-sialyllactose in patients with GNE myopathy: Randomized pilot trial.
Topics: Distal Myopathies; Humans; Muscle, Skeletal; Mutation; N-Acetylneuraminic Acid; Pilot Projects; Treatment Outcome | 2023 |
1 other study(ies) available for n-acetylneuraminoyllactose and Distal Myopathies
Article | Year |
---|---|
Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.
Topics: Aging; Amyloid beta-Peptides; Animals; Body Weight; Cells, Cultured; Creatine Kinase; Disease Models, Animal; Distal Myopathies; Enzyme-Linked Immunosorbent Assay; Hexosamines; Lactose; Mice; Muscle Contraction; Muscle, Skeletal; Mutation; Myoblasts; N-Acetylneuraminic Acid; Peptide Fragments; Phenotype | 2014 |